Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
about
Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.Maternal plasma soluble TRAIL is decreased in preeclampsia.Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaaMaternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.Increased serum levels of inflammatory mediators and low frequency of regulatory T cells in the peripheral blood of preeclamptic Mexican women.Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational studyDoppler ultrasound evaluation in preeclampsiaSerum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsiaEndothelial-derived hyperpolarization factor (EDHF) contributes to PlGF-induced dilation of mesenteric resistance arteries from pregnant rats.Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies.Differential Expression of Extracellular Matrix and Adhesion Molecules in Fetal-Origin Amniotic Epithelial Cells of Preeclamptic Pregnancy.Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsiaBiomarkers for the management of pre-eclampsia in pregnant women.The influence of oxidative stress and autophagy cross regulation on pregnancy outcome.Early Prognostic Factors for the Progress of Preeclampsia - Our Experience in the Period 2010-2011.IL-27 activates human trophoblasts to express IP-10 and IL-6: implications in the immunopathophysiology of preeclampsia.Fetal DNA in maternal plasma in preeclamptic pregnancies.Angiogenic imbalance and plasma lipid alterations in women with preeclampsia from a developing country.Serum levels of platelet endothelial cell adhesion molecule-1 (PECAM-1) and soluble vascular endothelial growth factor receptor (sVEGFR)-1 and -2 in HIV associated preeclampsia.Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.Fetal sex dependency of maternal vascular adaptation to pregnancy: a prospective population-based cohort study.Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy.Does immediate postpartum curettage of the endometrium accelerate recovery from preeclampsia-eclampsia? A randomized controlled trial.The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.Early pregnancy angiogenic proteins levels and pregnancy related hypertensive disorders.Decreased circulating anandamide levels in preeclampsia.Vitamin D restores angiogenic balance and decreases tumor necrosis factor-α in a rat model of pre-eclampsia.Clinical evaluations of cell-free fetal DNA quantities in pre-eclamptic pregnancies.Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia.Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia.Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome.
P2860
Q33863973-D9ED0FA4-055E-46D6-980D-D66D168FF5A4Q33909572-75143312-10F7-4DE5-AA08-6DADD2DD10DFQ34119026-53871327-1896-4765-8019-6E38E3E54778Q34182374-15F2ABB4-BD88-4E12-B459-5852D33595D2Q34619975-19430D04-933A-455F-9D95-F3F2B3767F4DQ34778624-A1950EBD-A330-4AE3-AF33-EC9ADE8DDD5CQ34929017-1BCCA6C1-9868-4EDB-9394-E8EBDC489D63Q35046946-853CA321-02E6-4A3F-A0DC-5B5D24755EAFQ35252411-DC54C20A-DA2D-47E8-A0A1-C2F631B39611Q35564789-19B74861-E699-4387-A8B8-0406A79D57D3Q35567911-047981DB-CAFE-4558-9F8E-87E55840CE78Q36027832-2DADCCD2-1A4F-4B48-B657-3D85139AAF59Q36062460-559FDB54-D2AE-4F77-9D10-882F2363994AQ36694041-B73F54C9-4826-4E05-AD9D-2705AF855082Q37156676-A12F83A4-CEAA-4F80-8B52-1893B4BD78A0Q37214857-DCC1C724-D964-4C32-A210-5C771F5E491DQ37297222-E0213375-D22C-423E-9941-B4725F4B37E2Q37603257-2A07106D-BA23-4247-A322-D9F6525FB3B8Q38257762-BBDAA0FA-2A02-4EDE-A728-15D2AD32902DQ39631618-C4253659-014F-43E5-9C78-DAD89CA7D71CQ40174475-79C632F6-203F-41BF-B972-FB29222863A2Q41033848-888AAF68-DF54-4F72-B311-82A0E77E3E0FQ41582146-88010D05-E47E-4ECB-A3FC-2F7BE63C60B3Q43689140-FC4EDCE0-68B9-4D19-AA73-9CB9DF3DD739Q46438791-D92A8468-AA04-4DEC-B253-B620F99FC375Q49312791-5C05B160-4A12-4B39-A2FB-417446C01E25Q50660057-15B9169F-9B6E-4414-A019-1902629BB5D8Q51051464-DF60C51A-4F50-467B-AE66-182DAF743A01Q51318293-29AD12E3-B43F-4B26-A32D-E1DFA45C4359Q54285680-A946564A-4C95-402C-BCAC-CD2C7096734FQ54506373-77E86161-CE43-4A98-A01A-704F0ABC3FA4Q54580713-AF28DA7A-C4BD-4ACD-993F-DC96BEE50BB9Q55003601-348CFFA2-3A0A-4B89-BCAD-7D6AFC9984D5
P2860
Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Circulating angiogenic factors ...... s in women with pre-eclampsia.
@en
Circulating angiogenic factors ...... s in women with pre-eclampsia.
@nl
type
label
Circulating angiogenic factors ...... s in women with pre-eclampsia.
@en
Circulating angiogenic factors ...... s in women with pre-eclampsia.
@nl
prefLabel
Circulating angiogenic factors ...... s in women with pre-eclampsia.
@en
Circulating angiogenic factors ...... s in women with pre-eclampsia.
@nl
P2093
P2860
P356
P1476
Circulating angiogenic factors ...... s in women with pre-eclampsia.
@en
P2093
András Szarka
Bálint Nagy
Endre Szucs
János Rigó
Szilvia Walentin
P2860
P2888
P304
P356
10.1038/HR.2010.92
P577
2010-06-10T00:00:00Z
P6179
1005567167